A machine learning model for prediction of preeclampsia risk using routinely collected data was feasible among pregnancies in ...
It is, in many ways, the defining story of endometriosis care in the U.S. Endometriosis affects an estimated 10% of ...
The smart algorithm successfully targeted pulmonary capillary wedge pressure (PCWP) 8-12 mmHg during rest/exercise and PCWP ...
Achilles tendon injuries are common in every sport involving running, cutting, and abrupt stops and starts, and it only gets ...
As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...
Obinutuzumab is a potent anti-B cell drug already approved to treat lupus nephritis, chronic lymphocytic leukemia, and follicular lymphoma. Therapies targeting B cells are perhaps the most effective ...
Morning light resets the rhythm. By evening, levels of a hormone called melatonin begin to surge, triggering drowsiness. Too much light in the evening -- that extra hour from daylight saving time -- ...
A promising combination for multiple myeloma received FDA approval as a second-line therapy. The approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase (Darzalex Faspro) stipulates use in ...
The loss of staff means the NIH has "lost so much of that institutional knowledge and leadership, which is not something that is easy or can be learned overnight," she said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results